Clinical Trial Update: Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether preventative topiramate (Topamax) influences the effectiveness of almotriptan (Axert) for acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Axert (Almotriptan)
• Topamax (Topiramate)

Snippet

Sponsor: Janssen-Ortho LLC | Conditions: Migraine, Classic Migraine | Phase 4 | Status: COMPLETED